
Gary W. Counts
Examiner (ID: 5481, Phone: (571)272-0817 , Office: P/1678 )
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1641, 1678, 1677 |
| Total Applications | 1282 |
| Issued Applications | 604 |
| Pending Applications | 186 |
| Abandoned Applications | 499 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19529524
[patent_doc_number] => 20240353426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => Methods for Diagnosing and Treating Ischemic Eye Disease
[patent_app_type] => utility
[patent_app_number] => 18/683069
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18683069
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/683069 | Methods for Diagnosing and Treating Ischemic Eye Disease | Aug 10, 2022 | Pending |
Array
(
[id] => 17991285
[patent_doc_number] => 20220357322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHODS AND MATERIALS FOR IDENTIFYING AND TREATING AUTOIMMUNE GFAP ASTROCYTOPATHY
[patent_app_type] => utility
[patent_app_number] => 17/870477
[patent_app_country] => US
[patent_app_date] => 2022-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17870477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/870477 | Methods and materials for identifying and treating autoimmune GFAP astrocytopathy | Jul 20, 2022 | Issued |
Array
(
[id] => 18254846
[patent_doc_number] => 20230081885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => BIOMARKERS FOR DIAGNOSING IMPLANT RELATED RISK OF IMPLANT REVISION DUE TO ASEPTIC LOOSENING
[patent_app_type] => utility
[patent_app_number] => 17/812537
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812537
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812537 | Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening | Jul 13, 2022 | Issued |
Array
(
[id] => 17931102
[patent_doc_number] => 20220326227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => IMMUNOCHROMATOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 17/851215
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851215 | IMMUNOCHROMATOGRAPHY | Jun 27, 2022 | Pending |
Array
(
[id] => 18308068
[patent_doc_number] => 20230111968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis
[patent_app_type] => utility
[patent_app_number] => 17/851613
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851613
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851613 | Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis | Jun 27, 2022 | Abandoned |
Array
(
[id] => 19475016
[patent_doc_number] => 12105095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Assay to detect and quantitate specific antibodies for various redox forms of HMGB1
[patent_app_type] => utility
[patent_app_number] => 17/848804
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 22
[patent_no_of_words] => 9844
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848804 | Assay to detect and quantitate specific antibodies for various redox forms of HMGB1 | Jun 23, 2022 | Issued |
Array
(
[id] => 19362141
[patent_doc_number] => 20240264175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => METHOD FOR ASSESSING RISK OF HEMORRHAGIC STROKE USING SOLUBLE CLEC2
[patent_app_type] => utility
[patent_app_number] => 18/565258
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18565258
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/565258 | METHOD FOR ASSESSING RISK OF HEMORRHAGIC STROKE USING SOLUBLE CLEC2 | May 30, 2022 | Pending |
Array
(
[id] => 19092053
[patent_doc_number] => 11953500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Detection reagent and therapeutic target for B cell tumor after targeted therapy and related application
[patent_app_type] => utility
[patent_app_number] => 17/824162
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10057
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/824162 | Detection reagent and therapeutic target for B cell tumor after targeted therapy and related application | May 24, 2022 | Issued |
Array
(
[id] => 17838955
[patent_doc_number] => 20220276260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => GLUCURONYLATION AS A NEW ACIDIC POST-TRANSLATIONAL MODIFICATION ON THERAPEUTIC MONOCLONAL ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/745140
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745140
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745140 | GLUCURONYLATION AS A NEW ACIDIC POST-TRANSLATIONAL MODIFICATION ON THERAPEUTIC MONOCLONAL ANTIBODIES | May 15, 2022 | Abandoned |
Array
(
[id] => 19382307
[patent_doc_number] => 20240272177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS
[patent_app_type] => utility
[patent_app_number] => 18/561621
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561621
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561621 | sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS | May 15, 2022 | Pending |
Array
(
[id] => 19114051
[patent_doc_number] => 20240125801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => MARKER FOR DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/276218
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276218
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276218 | MARKER FOR DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE | May 12, 2022 | Pending |
Array
(
[id] => 17838954
[patent_doc_number] => 20220276259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => METHODS FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS
[patent_app_type] => utility
[patent_app_number] => 17/743289
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743289
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743289 | METHODS FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS | May 11, 2022 | Abandoned |
Array
(
[id] => 17831488
[patent_doc_number] => 20220268792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/735555
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735555
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735555 | COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS | May 2, 2022 | Pending |
Array
(
[id] => 17831487
[patent_doc_number] => 20220268791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/735524
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735524 | Compositions and methods for the detection of host cell proteins | May 2, 2022 | Issued |
Array
(
[id] => 20454076
[patent_doc_number] => 12517128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Sample collection and analysis
[patent_app_type] => utility
[patent_app_number] => 17/735836
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 0
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735836 | Sample collection and analysis | May 2, 2022 | Issued |
Array
(
[id] => 20069913
[patent_doc_number] => 20250208135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-26
[patent_title] => Biomarkers for Neurodegenerative Disease
[patent_app_type] => utility
[patent_app_number] => 18/557941
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557941
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557941 | Biomarkers for Neurodegenerative Disease | Apr 27, 2022 | Pending |
Array
(
[id] => 19136461
[patent_doc_number] => 11971407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Detection of anti-p53 antibodies
[patent_app_type] => utility
[patent_app_number] => 17/730403
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5882
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730403 | Detection of anti-p53 antibodies | Apr 26, 2022 | Issued |
Array
(
[id] => 17983869
[patent_doc_number] => 20220349905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => METHODS AND DEVICES FOR QUANTITATIVELY ESTIMATING SYNDECAN-1
[patent_app_type] => utility
[patent_app_number] => 17/715294
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715294 | Methods and devices for quantitatively estimating syndecan-1 | Apr 6, 2022 | Issued |
Array
(
[id] => 19433866
[patent_doc_number] => 20240302364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => Compositions and Methods of Detecting Analytes
[patent_app_type] => utility
[patent_app_number] => 18/551159
[patent_app_country] => US
[patent_app_date] => 2022-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551159
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551159 | Compositions and Methods of Detecting Analytes | Apr 2, 2022 | Pending |
Array
(
[id] => 20220961
[patent_doc_number] => 20250283892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1)
[patent_app_type] => utility
[patent_app_number] => 18/551454
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551454
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551454 | DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1) | Mar 21, 2022 | Pending |